首页 > 最新文献

Narra J最新文献

英文 中文
Challenges and adversities among doctors in the era of healthcare disruption: Reflection from COVID-19 pandemic. 医疗保健混乱时代医生面临的挑战和逆境:COVID-19大流行的反思。
Pub Date : 2023-08-01 Epub Date: 2023-08-16 DOI: 10.52225/narraj.v3i2.134
Tri A Sugiyatmi, Usman Hadi, Djazuly Chalidyanto, Yashwant Pathak, Muhammad Miftahussurur

The doctor's profession is noble and tied up with quite strict rules, both in terms of ethics as well as discipline. Naturally, there is a problem of asymmetrical information between doctors and patients, often leading to misunderstandings. The purpose of this review is to map the available evidence related to the challenges and difficulties faced by doctors in the era of disruption. The evidence indicate that disruption of health services has both positive and negative effects. Many aspects related to the use of technology in the medical practices including innovation, cost-effectiveness, and quality improvement. However, psychologically, the doctors often get frustrated by internal or external triggers. The external factors, ranges from the equipment and work procedures, for instance, using high technology, communication with management, inter-professional relationships, patients, and their families. Volatility, uncertainty, complexity, and ambiguity (VUCA) could cause stress and burnout. In this case, doctors are highly vulnerable, and consequently, have the potential to make mistakes. Therefore, the adversity faced by doctors ought to be mapped. Resilience is a barrier against stress and burnout and the ability to adapt in resilience among doctors is important factor in dealing with the disruption era.

医生的职业是高尚的,在道德和纪律方面都有相当严格的规定。当然,医生和患者之间也存在信息不对称的问题,经常会产生误解。本综述的目的是梳理与医生在混乱时代所面临的挑战和困难有关的现有证据。证据表明,医疗服务的中断既有积极影响,也有消极影响。与医疗实践中使用技术有关的许多方面包括创新、成本效益和质量改进。然而,在心理上,医生往往会因为内部或外部的诱因而感到沮丧。外部因素包括设备和工作程序,例如使用高科技、与管理层的沟通、跨专业关系、病人及其家属。波动性、不确定性、复杂性和模糊性(VUCA)可能导致压力和职业倦怠。在这种情况下,医生非常容易受到伤害,因此有可能犯错误。因此,应该对医生面临的逆境进行摸底。应变能力是抵御压力和职业倦怠的屏障,医生的应变能力是应对混乱时代的重要因素。
{"title":"Challenges and adversities among doctors in the era of healthcare disruption: Reflection from COVID-19 pandemic.","authors":"Tri A Sugiyatmi, Usman Hadi, Djazuly Chalidyanto, Yashwant Pathak, Muhammad Miftahussurur","doi":"10.52225/narraj.v3i2.134","DOIUrl":"10.52225/narraj.v3i2.134","url":null,"abstract":"<p><p>The doctor's profession is noble and tied up with quite strict rules, both in terms of ethics as well as discipline. Naturally, there is a problem of asymmetrical information between doctors and patients, often leading to misunderstandings. The purpose of this review is to map the available evidence related to the challenges and difficulties faced by doctors in the era of disruption. The evidence indicate that disruption of health services has both positive and negative effects. Many aspects related to the use of technology in the medical practices including innovation, cost-effectiveness, and quality improvement. However, psychologically, the doctors often get frustrated by internal or external triggers. The external factors, ranges from the equipment and work procedures, for instance, using high technology, communication with management, inter-professional relationships, patients, and their families. Volatility, uncertainty, complexity, and ambiguity (VUCA) could cause stress and burnout. In this case, doctors are highly vulnerable, and consequently, have the potential to make mistakes. Therefore, the adversity faced by doctors ought to be mapped. Resilience is a barrier against stress and burnout and the ability to adapt in resilience among doctors is important factor in dealing with the disruption era.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e134"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10916102/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of N-acetylcysteine in decreasing neutrophil-lymphocyte ratio in COVID-19 patients: A double-blind, randomized controlled trial. N-乙酰半胱氨酸在降低 COVID-19 患者中性粒细胞-淋巴细胞比率中的作用:双盲随机对照试验。
Pub Date : 2023-08-01 Epub Date: 2023-05-19 DOI: 10.52225/narraj.v3i2.121
Nurhasan A Prabowo, Marcelino A Megantara, Hendrastutik Apriningsih

N-acetylcysteine has antioxidant and anti-inflammatory activities that could potentially improve the clinical outcomes of coronavirus disease 2019 (COVID-19) patients. N-acetylcysteine potentially inhibits NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome and results in control oxidative stress and cytokine release in COVID-19 patients. The aim of this study was to assess the effect of N-acetylcysteine in reducing the neutrophil-lymphocyte ratio (NLR) in COVID-19 patients. A randomized controlled clinical trial was conducted among severe and moderate COVID-19 patients. The treatment group received oral 1200 mg daily of N-acetylcysteine (three times a day) and the standard care for COVID-19, while the control group received standard care for COVID-19 and a placebo. The NLR was determined on the first day of admission and after the seventh day of treatment. A paired Student t-test was used to compare the NLR before and after treatment while independent Student t-test was used to compare the NLR between treatment and control groups. A total of 40 severe and moderate COVID-19 were enrolled, 20 people in each group, with a mean age was 44.68±13.24 years old. The mean NLR on the first day was 9.44 in the treatment group and 8.84 in the control group. After the seventh day, the mean NLR was 4.27 and 11.54 in the treatment group and control group, respectively. The mean changes of NLR (the pre-treatment compared to post-treatment) in the treatment and control group were reduced 4.05 and increased 3.34, respectively. The NLR in treatment group significantly decreased compared to the control group (p<0.001). In conclusion, N-acetylcysteine 1200 mg daily could reduce the NLR in severe and moderate COVID-19 patients.

N-乙酰半胱氨酸具有抗氧化和抗炎活性,有可能改善2019年冠状病毒病(COVID-19)患者的临床疗效。N-乙酰半胱氨酸可抑制NLRP3(含NOD、LRR和pyrin结构域蛋白3)炎性体,从而控制COVID-19患者的氧化应激和细胞因子释放。本研究旨在评估 N-乙酰半胱氨酸对降低 COVID-19 患者中性粒细胞-淋巴细胞比率(NLR)的作用。研究人员在重度和中度 COVID-19 患者中开展了一项随机对照临床试验。治疗组每天口服 1200 毫克 N-乙酰半胱氨酸(每天三次),并接受 COVID-19 的标准治疗,而对照组则接受 COVID-19 的标准治疗和安慰剂。入院第一天和治疗第七天后测定 NLR。采用配对学生 t 检验比较治疗前后的 NLR,采用独立学生 t 检验比较治疗组和对照组的 NLR。重度和中度 COVID-19 共 40 人,每组 20 人,平均年龄(44.68±13.24)岁。治疗组第一天的平均 NLR 为 9.44,对照组为 8.84。第七天后,治疗组和对照组的平均 NLR 分别为 4.27 和 11.54。治疗组和对照组的 NLR 平均值变化(治疗前与治疗后相比)分别减少了 4.05 和增加了 3.34。与对照组相比,治疗组的 NLR 明显下降(P0.001)。总之,N-乙酰半胱氨酸每日 1200 毫克可降低重度和中度 COVID-19 患者的 NLR。
{"title":"The role of N-acetylcysteine in decreasing neutrophil-lymphocyte ratio in COVID-19 patients: A double-blind, randomized controlled trial.","authors":"Nurhasan A Prabowo, Marcelino A Megantara, Hendrastutik Apriningsih","doi":"10.52225/narraj.v3i2.121","DOIUrl":"10.52225/narraj.v3i2.121","url":null,"abstract":"<p><p>N-acetylcysteine has antioxidant and anti-inflammatory activities that could potentially improve the clinical outcomes of coronavirus disease 2019 (COVID-19) patients. N-acetylcysteine potentially inhibits NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome and results in control oxidative stress and cytokine release in COVID-19 patients. The aim of this study was to assess the effect of N-acetylcysteine in reducing the neutrophil-lymphocyte ratio (NLR) in COVID-19 patients. A randomized controlled clinical trial was conducted among severe and moderate COVID-19 patients. The treatment group received oral 1200 mg daily of N-acetylcysteine (three times a day) and the standard care for COVID-19, while the control group received standard care for COVID-19 and a placebo. The NLR was determined on the first day of admission and after the seventh day of treatment. A paired Student t-test was used to compare the NLR before and after treatment while independent Student t-test was used to compare the NLR between treatment and control groups. A total of 40 severe and moderate COVID-19 were enrolled, 20 people in each group, with a mean age was 44.68±13.24 years old. The mean NLR on the first day was 9.44 in the treatment group and 8.84 in the control group. After the seventh day, the mean NLR was 4.27 and 11.54 in the treatment group and control group, respectively. The mean changes of NLR (the pre-treatment compared to post-treatment) in the treatment and control group were reduced 4.05 and increased 3.34, respectively. The NLR in treatment group significantly decreased compared to the control group (<i>p<</i>0.001). In conclusion, N-acetylcysteine 1200 mg daily could reduce the NLR in severe and moderate COVID-19 patients.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e121"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between high sensitivity C reactive protein (Hs-CRP) and neutrophil-to- lymphocyte ratio (NLR) with functional capacity in post COVID-19 syndrome patients. 高敏 C 反应蛋白(Hs-CRP)和中性粒细胞与淋巴细胞比值(NLR)与 COVID-19 后综合征患者功能能力的相关性。
Pub Date : 2023-08-01 Epub Date: 2023-08-27 DOI: 10.52225/narra.v3i2.183
Nina Widasari, Teuku Heriansyah, Muhammad Ridwan, Haris Munirwan, Ferry D Kurniawan

Post coronavirus disease 2019 (COVID-19) syndrome is one of the causes of reduced functional capacity and work productivity, in particular for healthcare workers. The pathophysiology of the post COVID-19 syndrome is related to complex and multisystem inflammatory mechanisms, and cardiopulmonary exercise rehabilitation program is one of the efforts to improve the recovery process for patients with post COVID-19 syndrome. The aim of this study was to determine the correlation between the level of high sensitivity C-reactive protein (Hs-CRP) and neutrophil-to-lymphocyte ratio (NLR) with functional capacity (VO2max) in individuals with post-COVID-19 syndrome who received moderate- and high-intensity supervised cardiopulmonary exercise. A prospective cohort study was conducted at the Integrated Cardiac Rehabilitation Center of Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia. The supervised cardiopulmonary exercise was conducted for six weeks according to the participant's baseline VO2max. Spearman's and Pearson's correlation tests were used to assess the correlations. A total of 30 individuals (19 and 11 had moderate and high intensity exercise, respectively) were involved in this study. At moderate intensity exercise, the average Hs-CRP and NLR were 3.3 mg/L and 1.99, respectively; while at high intensity, the values were 3.8 mg/L and 1.79, respectively. No significant correlation between Hs-CRP level and functional capacity in both moderate-intensity and high intensity groups. In contrast, NLR was negatively correlated with functional capacity (r=-0.545, p=0.016) in moderate intensity exercise group. In conclusion, NLR value was negatively correlated with functional capacity in individuals with post-COVID-19 syndrome after receiving moderate intensity supervised cardiopulmonary exercise program. Therefore, moderate intensity of cardiopulmonary exercise maybe be used as a program to accelerate the recovery for those with post COVID-19 syndrome.

2019年冠状病毒病(COVID-19)后综合征是导致机能下降和工作效率降低的原因之一,尤其是对医护人员而言。COVID-19后综合征的病理生理学与复杂的多系统炎症机制有关,心肺运动康复计划是改善COVID-19后综合征患者康复进程的努力之一。本研究旨在确定接受中等强度和高强度有指导的心肺运动的后 COVID-19 综合征患者的高敏 C 反应蛋白(Hs-CRP)和中性粒细胞与淋巴细胞比值(NLR)水平与功能能力(VO2max)之间的相关性。印度尼西亚班达亚齐市扎伊诺尔-阿比丁博士医院心脏康复综合中心开展了一项前瞻性队列研究。根据受试者的基线 VO2max,进行了为期六周的有指导的心肺运动。采用斯皮尔曼和皮尔森相关检验来评估相关性。共有 30 人参与了这项研究(分别有 19 人和 11 人进行了中等强度和高强度运动)。中强度运动时,Hs-CRP 和 NLR 的平均值分别为 3.3 毫克/升和 1.99;而高强度运动时,这两个值分别为 3.8 毫克/升和 1.79。在中等强度组和高强度组中,Hs-CRP 水平与功能能力之间没有明显的相关性。相反,中等强度运动组的 NLR 与功能能力呈负相关(r=-0.545,p=0.016)。总之,COVID-19 后综合征患者在接受中等强度的有指导的心肺锻炼后,NLR 值与功能能力呈负相关。因此,中等强度的心肺运动可作为加速 COVID-19 后综合征患者康复的项目。
{"title":"Correlation between high sensitivity C reactive protein (Hs-CRP) and neutrophil-to- lymphocyte ratio (NLR) with functional capacity in post COVID-19 syndrome patients.","authors":"Nina Widasari, Teuku Heriansyah, Muhammad Ridwan, Haris Munirwan, Ferry D Kurniawan","doi":"10.52225/narra.v3i2.183","DOIUrl":"10.52225/narra.v3i2.183","url":null,"abstract":"<p><p>Post coronavirus disease 2019 (COVID-19) syndrome is one of the causes of reduced functional capacity and work productivity, in particular for healthcare workers. The pathophysiology of the post COVID-19 syndrome is related to complex and multisystem inflammatory mechanisms, and cardiopulmonary exercise rehabilitation program is one of the efforts to improve the recovery process for patients with post COVID-19 syndrome. The aim of this study was to determine the correlation between the level of high sensitivity C-reactive protein (Hs-CRP) and neutrophil-to-lymphocyte ratio (NLR) with functional capacity (VO<sub>2max</sub>) in individuals with post-COVID-19 syndrome who received moderate- and high-intensity supervised cardiopulmonary exercise. A prospective cohort study was conducted at the Integrated Cardiac Rehabilitation Center of Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia. The supervised cardiopulmonary exercise was conducted for six weeks according to the participant's baseline VO<sub>2max</sub>. Spearman's and Pearson's correlation tests were used to assess the correlations. A total of 30 individuals (19 and 11 had moderate and high intensity exercise, respectively) were involved in this study. At moderate intensity exercise, the average Hs-CRP and NLR were 3.3 mg/L and 1.99, respectively; while at high intensity, the values were 3.8 mg/L and 1.79, respectively. No significant correlation between Hs-CRP level and functional capacity in both moderate-intensity and high intensity groups. In contrast, NLR was negatively correlated with functional capacity (<i>r</i>=-0.545, <i>p</i>=0.016) in moderate intensity exercise group. In conclusion, NLR value was negatively correlated with functional capacity in individuals with post-COVID-19 syndrome after receiving moderate intensity supervised cardiopulmonary exercise program. Therefore, moderate intensity of cardiopulmonary exercise maybe be used as a program to accelerate the recovery for those with post COVID-19 syndrome.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e183"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10916408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of SGLT2 inhibitor administration on blood glucose level and body weight in type 1 diabetes rat model. 服用 SGLT2 抑制剂对 1 型糖尿病大鼠模型血糖水平和体重的影响
Pub Date : 2023-08-01 Epub Date: 2023-08-31 DOI: 10.52225/narra.v3i2.194
Maimun Syukri, Lia M Zaini, Arief S Kartasasmita, Tjahjono D Gondhowiardjo, Ronny Lesmana

The prevalence of diabetes worldwide is increasing and 629 million people are projected to have diabetes by 2045, and the most significant burden of the disease being concentrated in low- and middle-income countries (LMICs). Type 2 diabetes is mainly treated with insulin adjunctive therapies such as metformin to improve insulin sensitivity and sodium-glucose co-transporter 2 (SGLT2) inhibitors to lower blood glucose levels. However, there was limited study on the application of SGLT2 inhibitors on type 1 diabetes, particularly empagliflozin. Therefore, this study aimed to determine the effect of SGLT2 inhibitors on blood glucose levels and body weights in a rat model of type 1 diabetes. To mimic type 1 diabetes, the rats were injected with streptozotocin 60 mg intra-peritoneally. Twenty-four rat models were randomly divided into four groups: normal rat group (negative control), untreated diabetic rat group (positive control), type 1 diabetic rats treated with metformin, and type 1 diabetic rats treated with empagliflozin. Blood glucose levels and body weight were recorded before and after induced with streptozotocin and on weeks 4, 6, 8 and 10 of the treatment with anti-diabetic drugs. This study found that the blood glucose levels before and after treatment significantly decreased in all groups (p<0.05), except in the negative control group. Similar results were observed in body weight of the rats, which all groups experienced weight loss, except the negative control. These results suggested that apart from being used in type 2 diabetes, SGLT2 inhibitors may also be used as a treatment for type 1 diabetes.

全球糖尿病患病率不断上升,预计到 2045 年将有 6.29 亿人患糖尿病,而这一疾病造成的最沉重负担主要集中在中低收入国家(LMICs)。2 型糖尿病主要采用胰岛素辅助疗法治疗,如二甲双胍改善胰岛素敏感性,钠-葡萄糖协同转运体 2(SGLT2)抑制剂降低血糖水平。然而,有关 SGLT2 抑制剂(尤其是恩格列净)在 1 型糖尿病中应用的研究十分有限。因此,本研究旨在确定SGLT2抑制剂对1型糖尿病大鼠模型中血糖水平和体重的影响。为模拟 1 型糖尿病,大鼠腹腔注射链脲佐菌素 60 毫克。24 只大鼠模型被随机分为四组:正常大鼠组(阴性对照组)、未治疗的糖尿病大鼠组(阳性对照组)、使用二甲双胍治疗的 1 型糖尿病大鼠组和使用安格列净治疗的 1 型糖尿病大鼠组。在使用链脲佐菌素诱导前后以及使用抗糖尿病药物治疗的第 4、6、8 和 10 周,记录血糖水平和体重。研究发现,各组治疗前后的血糖水平均明显下降(p
{"title":"Effects of SGLT2 inhibitor administration on blood glucose level and body weight in type 1 diabetes rat model.","authors":"Maimun Syukri, Lia M Zaini, Arief S Kartasasmita, Tjahjono D Gondhowiardjo, Ronny Lesmana","doi":"10.52225/narra.v3i2.194","DOIUrl":"10.52225/narra.v3i2.194","url":null,"abstract":"<p><p>The prevalence of diabetes worldwide is increasing and 629 million people are projected to have diabetes by 2045, and the most significant burden of the disease being concentrated in low- and middle-income countries (LMICs). Type 2 diabetes is mainly treated with insulin adjunctive therapies such as metformin to improve insulin sensitivity and sodium-glucose co-transporter 2 (SGLT2) inhibitors to lower blood glucose levels. However, there was limited study on the application of SGLT2 inhibitors on type 1 diabetes, particularly empagliflozin. Therefore, this study aimed to determine the effect of SGLT2 inhibitors on blood glucose levels and body weights in a rat model of type 1 diabetes. To mimic type 1 diabetes, the rats were injected with streptozotocin 60 mg intra-peritoneally. Twenty-four rat models were randomly divided into four groups: normal rat group (negative control), untreated diabetic rat group (positive control), type 1 diabetic rats treated with metformin, and type 1 diabetic rats treated with empagliflozin. Blood glucose levels and body weight were recorded before and after induced with streptozotocin and on weeks 4, 6, 8 and 10 of the treatment with anti-diabetic drugs. This study found that the blood glucose levels before and after treatment significantly decreased in all groups (<i>p</i><0.05), except in the negative control group. Similar results were observed in body weight of the rats, which all groups experienced weight loss, except the negative control. These results suggested that apart from being used in type 2 diabetes, SGLT2 inhibitors may also be used as a treatment for type 1 diabetes.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e194"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and oral microbiome pattern of halitosis patients with periodontitis and gingivitis. 牙周炎和牙龈炎口臭患者的临床和口腔微生物组模式。
Pub Date : 2023-08-01 Epub Date: 2023-07-11 DOI: 10.52225/narra.v3i2.163
Diana S Ningsih, Rinaldi Idroes, Boy M Bachtiar, Khairan Khairan, Trina E Tallei, Pati Kemala, Nur B Maulydia, Ghazi M Idroes, Zuchra Helwani

Halitosis is caused by a bacterial proteolytic process that induces the production of volatile sulfur compounds, odor-causing gases. The aim of this study was to determine the clinical oral hygiene state and oral microbiome pattern of halitosis patients with periodontitis and gingivitis. The oral hygiene state of halitosis patients with periodontitis and gingivitis was assessed using the oral hygiene index simplified (OHI-S), decay missing filled teeth (DMFT), and tongue biofilm. The dorsum of the tongue and subgingival swabs were cultured for bacteria, and bacterial morphology was evaluated using Gram staining. Evaluation of the bacterial genus using the Bergey's systematic bacteriology diagram as a guide. A total of ten patients with periodontitis and gingivitis were included. Our data indicated that the scores of OHI-S and DMFT were different significantly between halitosis patients with periodontitis and gingivitis (both had p<0.001) while tongue biofilm score was not different between groups. On the dorsum of the tongue, periodontitis patients had a significant higher oral microbiome population (85.65x106 CFU/mL) compared to those with gingivitis (0.047x106 CFU/mL) with p=0.002. In contrast, the number of microbiomes in the subgingival had no significant different between periodontitis and gingivitis. On the dorsum of the tongue, six bacterial genera were isolated from periodontitis cases and seven genera were detected from gingivitis patients. On subgingival, 10 and 15 genera were identified from periodontitis and gingivitis, respectively. Fusobacterium, Propionibacterium, Eubacterium and Lactobacillus were the most prevalent among periodontitis cases while Porphyromonas was the most prevalent in gingivitis patients. In conclusion, although OHI-S and DMFT are different between periodontitis and gingivitis, overlapping of bacterial genera was detected between periodontitis and gingivitis cases.

口臭是由细菌的蛋白分解过程引起的,这种过程会诱发产生挥发性硫化物这种致臭气体。本研究旨在确定患有牙周炎和牙龈炎的口臭患者的临床口腔卫生状态和口腔微生物组模式。研究采用简化口腔卫生指数(OHI-S)、龋坏缺失补牙(DMFT)和舌生物膜评估牙周炎和牙龈炎口臭患者的口腔卫生状况。对舌背和龈下拭子进行细菌培养,并使用革兰氏染色法评估细菌形态。以 Bergey 系统细菌学图为指导评估细菌属。共纳入了十名牙周炎和牙龈炎患者。我们的数据表明,与牙龈炎患者(0.047x106 CFU/mL)相比,牙周炎和牙龈炎口臭患者(两者的CFU/mL均为p6)的OHI-S和DMFT评分有显著差异,p=0.002。相比之下,牙周炎和牙龈炎患者龈下微生物群的数量没有显著差异。在舌背上,牙周炎病例分离出 6 个细菌属,牙龈炎患者分离出 7 个细菌属。在龈下,牙周炎和牙龈炎患者分别发现了 10 个和 15 个细菌属。在牙周炎病例中最常见的是镰刀菌属、丙酸杆菌属、优杆菌属和乳酸杆菌属,而在牙龈炎患者中最常见的是卟啉单胞菌属。总之,虽然牙周炎和牙龈炎的OHI-S和DMFT不同,但牙周炎和牙龈炎病例的细菌属有重叠。
{"title":"Clinical and oral microbiome pattern of halitosis patients with periodontitis and gingivitis.","authors":"Diana S Ningsih, Rinaldi Idroes, Boy M Bachtiar, Khairan Khairan, Trina E Tallei, Pati Kemala, Nur B Maulydia, Ghazi M Idroes, Zuchra Helwani","doi":"10.52225/narra.v3i2.163","DOIUrl":"10.52225/narra.v3i2.163","url":null,"abstract":"<p><p>Halitosis is caused by a bacterial proteolytic process that induces the production of volatile sulfur compounds, odor-causing gases. The aim of this study was to determine the clinical oral hygiene state and oral microbiome pattern of halitosis patients with periodontitis and gingivitis. The oral hygiene state of halitosis patients with periodontitis and gingivitis was assessed using the oral hygiene index simplified (OHI-S), decay missing filled teeth (DMFT), and tongue biofilm. The dorsum of the tongue and subgingival swabs were cultured for bacteria, and bacterial morphology was evaluated using Gram staining. Evaluation of the bacterial genus using the Bergey's systematic bacteriology diagram as a guide. A total of ten patients with periodontitis and gingivitis were included. Our data indicated that the scores of OHI-S and DMFT were different significantly between halitosis patients with periodontitis and gingivitis (both had <i>p</i><0.001) while tongue biofilm score was not different between groups. On the dorsum of the tongue, periodontitis patients had a significant higher oral microbiome population (85.65x10<sup>6</sup> CFU/mL) compared to those with gingivitis (0.047x10<sup>6</sup> CFU/mL) with <i>p</i>=0.002. In contrast, the number of microbiomes in the subgingival had no significant different between periodontitis and gingivitis. On the dorsum of the tongue, six bacterial genera were isolated from periodontitis cases and seven genera were detected from gingivitis patients. On subgingival, 10 and 15 genera were identified from periodontitis and gingivitis, respectively. Fusobacterium, Propionibacterium, Eubacterium and Lactobacillus were the most prevalent among periodontitis cases while Porphyromonas was the most prevalent in gingivitis patients. In conclusion, although OHI-S and DMFT are different between periodontitis and gingivitis, overlapping of bacterial genera was detected between periodontitis and gingivitis cases.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e163"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety evaluation and effects of cascara pulp Gayo Arabica coffee cream as anti-photoaging in animal model. 在动物模型中使用 cascara pulp Gayo Arabica 咖啡膏作为抗照片老化药物的安全性评估和效果。
Pub Date : 2023-08-01 Epub Date: 2023-08-31 DOI: 10.52225/narra.v3i2.204
Wahyu Lestari, Sitti Hajar

Prolonged sunlight and ultraviolet (UV) exposure causes premature skin aging called photoaging and coffee-derived topical antioxidants may help to reduce this process. Since a significant amount of antioxidant-rich cascara pulp are wasted in coffee processing, this study aimed to evaluate the safety of cascara extract cream of Gayo Arabica coffee pulp (CECGACP) as anti-photoaging in male Wistar rats (Rattus norvegicus) by assessing the skin primary irritation index (PII), skin macroscopic changes and the level of tumor necrosis factor-alpha (TNF-α). Twenty-five rats were randomly divided into five different groups: negative control (base cream only), positive control containing L-ascorbic acid 3%, and three treatment groups treated with cream containing 5%, 7.5% and 10% of CECGACP. The CECGACP was extracted, formulated into cream as a topical treatment and applied on the backs of the rats two times a day, once before the UV exposure and four hours after the exposure. After four weeks, the skins were macroscopically examined, and the TNF-α levels were measured. The PII was assessed after applying the cream 24 hours before UX exposure. Our data suggested that CECGACP was considered safe because there were no erythema and edema formation on the skin of the rats with PII score of 0 (classified as no irritation or negligible). After UV exposure, all rats had visible wrinkles and erythema on the skin in particular in the first week. After administration of CECGACP, both wrinkles and erythema were decreased. The levels of TNF-α varied from 0.15±0.02 ng/mL in the negative control and CECGACP 7.5% rat groups to 0.19±0.03 in the positive control group; however, there was no significant difference among all the groups. Our study suggests that CECGACP is safe to use in Wistar rats and able to reduce the erythema and edema due to UV exposure. However, the application of CECGACP does not provide a significant reduction of TNF-α levels.

长时间的阳光和紫外线(UV)照射会导致皮肤过早老化,称为光老化,而从咖啡中提取的局部抗氧化剂可能有助于减少这一过程。由于咖啡加工过程中浪费了大量富含抗氧化剂的咖啡果肉,本研究旨在通过评估雄性 Wistar 大鼠(Rattus norvegicus)的皮肤原发性刺激指数(PII)、皮肤宏观变化和肿瘤坏死因子-α(TNF-α)水平,评估阿拉伯加优咖啡果肉中的咖啡果提取物霜(CECGACP)作为抗光老化药物的安全性。25 只大鼠被随机分为五个不同的组别:阴性对照组(仅基底乳霜)、含 3% 左旋抗坏血酸的阳性对照组和含 5%、7.5% 和 10% CECGACP 的乳霜的三个治疗组。提取 CECGACP 后,将其配制成外用药膏,每天两次涂抹在大鼠背部,一次在紫外线照射前,另一次在紫外线照射后四小时。四周后,对皮肤进行宏观检查,并测量 TNF-α 的水平。在紫外线照射前 24 小时涂抹面霜后,对 PII 进行了评估。我们的数据表明,CECGACP 是安全的,因为大鼠皮肤上没有红斑和水肿形成,PII 得分为 0(归类为无刺激或可忽略不计)。紫外线照射后,所有大鼠的皮肤都出现了明显的皱纹和红斑,尤其是在第一周。施用 CECGACP 后,皱纹和红斑都有所减少。TNF-α 的水平从阴性对照组和 CECGACP 7.5% 大鼠组的 0.15±0.02 ng/mL 到阳性对照组的 0.19±0.03,但各组之间没有显著差异。我们的研究表明,在 Wistar 大鼠中使用 CECGACP 是安全的,并且能够减轻紫外线照射引起的红斑和水肿。然而,使用 CECGACP 并不能显著降低 TNF-α 的水平。
{"title":"Safety evaluation and effects of cascara pulp Gayo Arabica coffee cream as anti-photoaging in animal model.","authors":"Wahyu Lestari, Sitti Hajar","doi":"10.52225/narra.v3i2.204","DOIUrl":"10.52225/narra.v3i2.204","url":null,"abstract":"<p><p>Prolonged sunlight and ultraviolet (UV) exposure causes premature skin aging called photoaging and coffee-derived topical antioxidants may help to reduce this process. Since a significant amount of antioxidant-rich cascara pulp are wasted in coffee processing, this study aimed to evaluate the safety of cascara extract cream of Gayo Arabica coffee pulp (CECGACP) as anti-photoaging in male Wistar rats (<i>Rattus norvegicus</i>) by assessing the skin primary irritation index (PII), skin macroscopic changes and the level of tumor necrosis factor-alpha (TNF-α). Twenty-five rats were randomly divided into five different groups: negative control (base cream only), positive control containing L-ascorbic acid 3%, and three treatment groups treated with cream containing 5%, 7.5% and 10% of CECGACP. The CECGACP was extracted, formulated into cream as a topical treatment and applied on the backs of the rats two times a day, once before the UV exposure and four hours after the exposure. After four weeks, the skins were macroscopically examined, and the TNF-α levels were measured. The PII was assessed after applying the cream 24 hours before UX exposure. Our data suggested that CECGACP was considered safe because there were no erythema and edema formation on the skin of the rats with PII score of 0 (classified as no irritation or negligible). After UV exposure, all rats had visible wrinkles and erythema on the skin in particular in the first week. After administration of CECGACP, both wrinkles and erythema were decreased. The levels of TNF-α varied from 0.15±0.02 ng/mL in the negative control and CECGACP 7.5% rat groups to 0.19±0.03 in the positive control group; however, there was no significant difference among all the groups. Our study suggests that CECGACP is safe to use in Wistar rats and able to reduce the erythema and edema due to UV exposure. However, the application of CECGACP does not provide a significant reduction of TNF-α levels.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e204"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10916414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Celiac disease: Pathogenesis, disease management and new insights into the herbal-based treatments. 乳糜泻:发病机制、疾病管理和草药治疗新见解。
Pub Date : 2023-08-01 Epub Date: 2023-07-12 DOI: 10.52225/narra.v3i2.147
Pooja Mittal, Disha Arora, Smriti Parashar, Rajat Goyal, Amir Khan, Hitesh Chopra, Dinesh K Mishra, Rupesh K Gautam, Kuldeep Dhama

Celiac disease (CD) is a gluten intolerance autoimmune disorder which its symptoms involve the gastrointestinal tract and sometimes the other organs. It is one of the most prevalent health problems rising in many populations as statistics show that in every 100 people about one person is suffering from CD. It has been observed that the persons who genetically contain the human leukocyte antigen (HLA) DQ2 and HLA DQ8 genes involved in the immune system haplotypes are more prone to develop an allergy to gluten. The only treatment currently available for CD is a strict gluten-free diet. However, recent research has shown promising new insights into the herbal-based treatments of CD. New insight on CD is now offering various prospects to manage its treatment, diagnosis, and serving in the development of advanced therapies. Several herbs and botanical extracts have demonstrated anti-inflammatory, immunomodulatory, and gut-healing properties that make them potential candidates for the management of CD. Here, we provide an updated review on pathogeneses and managements of CD. In particular, we summarize the current understandings of herbal-based treatments for CD and highlights their potential benefits.

乳糜泻(CD)是一种麸质不耐受的自身免疫性疾病,其症状涉及胃肠道,有时也涉及其他器官。据统计,每 100 人中就有一人患有乳糜泻,因此它是许多人群中最普遍的健康问题之一。据观察,基因中含有人类白细胞抗原(HLA)DQ2 和 HLA DQ8 基因的免疫系统单倍型患者更容易对麸质过敏。目前治疗 CD 的唯一方法是严格的无麸质饮食。然而,最近的研究表明,以草药为基础的 CD 治疗方法前景广阔。对 CD 的新认识为 CD 的治疗、诊断和先进疗法的开发提供了各种前景。一些草药和植物提取物具有抗炎、免疫调节和肠道愈合的特性,使其成为治疗 CD 的潜在候选药物。在此,我们对 CD 的病因和治疗方法进行了最新综述。特别是,我们总结了目前对以草药为基础的 CD 治疗方法的理解,并强调了它们的潜在益处。
{"title":"Celiac disease: Pathogenesis, disease management and new insights into the herbal-based treatments.","authors":"Pooja Mittal, Disha Arora, Smriti Parashar, Rajat Goyal, Amir Khan, Hitesh Chopra, Dinesh K Mishra, Rupesh K Gautam, Kuldeep Dhama","doi":"10.52225/narra.v3i2.147","DOIUrl":"10.52225/narra.v3i2.147","url":null,"abstract":"<p><p>Celiac disease (CD) is a gluten intolerance autoimmune disorder which its symptoms involve the gastrointestinal tract and sometimes the other organs. It is one of the most prevalent health problems rising in many populations as statistics show that in every 100 people about one person is suffering from CD. It has been observed that the persons who genetically contain the human leukocyte antigen (HLA) DQ2 and HLA DQ8 genes involved in the immune system haplotypes are more prone to develop an allergy to gluten. The only treatment currently available for CD is a strict gluten-free diet. However, recent research has shown promising new insights into the herbal-based treatments of CD. New insight on CD is now offering various prospects to manage its treatment, diagnosis, and serving in the development of advanced therapies. Several herbs and botanical extracts have demonstrated anti-inflammatory, immunomodulatory, and gut-healing properties that make them potential candidates for the management of CD. Here, we provide an updated review on pathogeneses and managements of CD. In particular, we summarize the current understandings of herbal-based treatments for CD and highlights their potential benefits.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e147"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life and its predictors among people living with HIV in Muslim majority region: A cross-sectional study in Aceh. 穆斯林占多数地区艾滋病毒感染者的生活质量及其预测因素:亚齐横断面研究。
Pub Date : 2023-08-01 Epub Date: 2023-08-31 DOI: 10.52225/narra.v3i2.202
Maryatun Hasan, Kurnia F Jamil, Darmawi Darmawi, Maimun Syukri, Tita M Liansyah, Anđelija Beočanin, Dava Erianza

Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) remain significant global health challenges addressed by countries worldwide. The advent of antiretroviral therapy (ARV) has significantly reduced morbidity and mortality of people living with HIV (PLHIV), transforming HIV/AIDS from a fatal disease to a manageable chronic disease. However, the increasing number of elderly individuals with HIV who experience early frailty syndrome presents new challenges and potential for diminished quality of life. The aim of this study was to assess the quality of life and to identify its significant predictors in PLHIV patients who have received ARV therapy in Banda Aceh, a Muslim-majority region in Indonesia. A cross-sectional study was conducted on all PLHIV who received ARV therapy at the voluntary counseling and testing (VCT) polyclinic at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia between January and February 2023. The WHOQOL-HIV BREF instrument, a multi-dimensional tool developed by the World Health Organization (WHO), was used to assess the quality of life of the PLHIV, and potential predictors were assessed. The Chi-squared test was used to determine the predictors associated with the quality of patient's lives. Our data indicated that the majority of PLHIV were male (88%), 26-35 years old (78%), employed (92%), and unmarried (54%). Poor quality of life was dominant for the physical health (100%) and social relationships (76%) domains. In contrast, good quality of life was observed in aspects of independence, psychology, and spirituality, all reporting 100% results. Significant associations were found between married status (p=0.004) and medication adherence (p<0.001) with higher quality of life among PLHIV. In conclusion, married PLHIVs that received support from their partners regarding adherence to therapy exhibited a better quality of life. These results underscore the significance of sustained support systems and adherence strategies to enhance PLHIV's quality of life.

人体免疫缺陷病毒(HIV)和获得性免疫缺陷综合征(AIDS)仍然是世界各国应对的重大全球健康挑战。抗逆转录病毒疗法(ARV)的出现大大降低了艾滋病毒感染者(PLHIV)的发病率和死亡率,使艾滋病毒/艾滋病从一种致命疾病转变为一种可以控制的慢性疾病。然而,越来越多的老年艾滋病病毒感染者出现了早期虚弱综合征,这带来了新的挑战,并有可能导致生活质量下降。本研究旨在评估印度尼西亚穆斯林占多数的班达亚齐地区接受抗逆转录病毒治疗的 PLHIV 患者的生活质量,并确定其重要的预测因素。这项横断面研究的对象是2023年1月至2月期间在印度尼西亚班达亚齐Zainoel Abidin博士医院自愿咨询和检测(VCT)综合诊所接受抗逆转录病毒治疗的所有艾滋病毒感染者。世界卫生组织(WHO)开发的多维工具WHOQOL-HIV BREF用于评估艾滋病毒感染者的生活质量,并对潜在的预测因素进行了评估。采用卡方检验来确定与患者生活质量相关的预测因素。我们的数据显示,大多数 PLHIV 患者为男性(88%)、26-35 岁(78%)、在职(92%)和未婚(54%)。生活质量差主要体现在身体健康(100%)和社会关系(76%)两个方面。相比之下,独立、心理和精神方面的生活质量较高,均为 100%。已婚状况(p=0.004)与服药依从性(p=0.005)之间存在显著关联。
{"title":"Quality of life and its predictors among people living with HIV in Muslim majority region: A cross-sectional study in Aceh.","authors":"Maryatun Hasan, Kurnia F Jamil, Darmawi Darmawi, Maimun Syukri, Tita M Liansyah, Anđelija Beočanin, Dava Erianza","doi":"10.52225/narra.v3i2.202","DOIUrl":"10.52225/narra.v3i2.202","url":null,"abstract":"<p><p>Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) remain significant global health challenges addressed by countries worldwide. The advent of antiretroviral therapy (ARV) has significantly reduced morbidity and mortality of people living with HIV (PLHIV), transforming HIV/AIDS from a fatal disease to a manageable chronic disease. However, the increasing number of elderly individuals with HIV who experience early frailty syndrome presents new challenges and potential for diminished quality of life. The aim of this study was to assess the quality of life and to identify its significant predictors in PLHIV patients who have received ARV therapy in Banda Aceh, a Muslim-majority region in Indonesia. A cross-sectional study was conducted on all PLHIV who received ARV therapy at the voluntary counseling and testing (VCT) polyclinic at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia between January and February 2023. The WHOQOL-HIV BREF instrument, a multi-dimensional tool developed by the World Health Organization (WHO), was used to assess the quality of life of the PLHIV, and potential predictors were assessed. The Chi-squared test was used to determine the predictors associated with the quality of patient's lives. Our data indicated that the majority of PLHIV were male (88%), 26-35 years old (78%), employed (92%), and unmarried (54%). Poor quality of life was dominant for the physical health (100%) and social relationships (76%) domains. In contrast, good quality of life was observed in aspects of independence, psychology, and spirituality, all reporting 100% results. Significant associations were found between married status (<i>p</i>=0.004) and medication adherence (<i>p</i><0.001) with higher quality of life among PLHIV. In conclusion, married PLHIVs that received support from their partners regarding adherence to therapy exhibited a better quality of life. These results underscore the significance of sustained support systems and adherence strategies to enhance PLHIV's quality of life.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e202"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic total occlusion percutaneous coronary intervention (CTO PCI) in an intractable heart failure patient: Is there any benefit? 顽固性心衰患者的慢性全闭塞经皮冠状动脉介入治疗(CTO PCI):是否有任何益处?
Pub Date : 2023-08-01 Epub Date: 2023-07-12 DOI: 10.52225/narra.v3i2.140
Haris Munirwan, Fahmi A Kusyanto, Zanisa Zanisa, Muhammad H Latief

One of the most difficult procedures in interventional cardiology is the percutaneous coronary intervention (PCI) on a chronic total occlusion (CTO) lesion case. To rate the difficulty of guidewire crossing, several angiographic scoring methods have been developed such as the Japan CTO (J-CTO) score. Here we demonstrate the advantages of revascularization using PCI procedure in a CTO case with intractable heart failure. A 53-year-old man presented to the emergency room of Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia with acute decompensated heart failure. The patient had a history of past PCI with two patent drug eluting stents (DES): one in the left main (LM)-left anterior descending (LAD) artery and one in the distal left circumflex (LCX) artery. The patient had three times rehospitalizations in the last three months. According to single-photon emission computed tomography (SPECT) imaging, the right coronary artery was remained functional; however, the lesion was categorized into very difficult level (J-CTO >3). The PCI was carried out on the right coronary artery and the blood vessel was successfully revascularized after applying multiple techniques. Following the procedure, the heart failure was treated and the 6-minute walking test (6MWT) that performed 12 days after the PCI increased from 220 to 260 meters. The success of this case depended on a comprehensive history taking, adequate imaging methods, and the selection of the proper tools and PCI strategy. In conclusion, despite the challenges, PCI is still an option for patients with persistent complete occlusion. The PCI requires comprehensive preparation and the use of angiographic scoring systems, such as the J-CTO score, to determine the approach and the likelihood of success.

介入心脏病学中最困难的手术之一是对慢性全闭塞(CTO)病变病例进行经皮冠状动脉介入治疗(PCI)。为了评定导丝穿刺的难度,已开发出多种血管造影评分方法,如日本 CTO(J-CTO)评分法。在此,我们展示了在一例伴有顽固性心衰的 CTO 病例中使用 PCI 程序进行血管再通的优势。一名 53 岁的男子因急性失代偿性心力衰竭来到印度尼西亚班达亚齐省扎伊诺尔-阿比丁博士医院急诊室就诊。患者既往曾使用两个专利药物洗脱支架(DES)进行过PCI手术:一个在左主干(LM)-左前降支(LAD)动脉,另一个在左环绕(LCX)动脉远端。患者在过去三个月中曾三次再次住院。根据单光子发射计算机断层扫描(SPECT)成像,右冠状动脉仍保持功能,但病变被归类为非常困难的级别(J-CTO >3)。对右冠状动脉实施了 PCI 术,并在应用多种技术后成功实现了血管再通。术后,心衰得到了治疗,PCI术后12天进行的6分钟步行测试(6MWT)从220米增加到260米。该病例的成功取决于全面的病史采集、充分的影像学方法以及选择适当的工具和 PCI 策略。总之,尽管存在挑战,PCI 仍是顽固性完全闭塞患者的一种选择。PCI 需要全面的准备,并使用血管造影评分系统(如 J-CTO 评分)来确定方法和成功的可能性。
{"title":"Chronic total occlusion percutaneous coronary intervention (CTO PCI) in an intractable heart failure patient: Is there any benefit?","authors":"Haris Munirwan, Fahmi A Kusyanto, Zanisa Zanisa, Muhammad H Latief","doi":"10.52225/narra.v3i2.140","DOIUrl":"10.52225/narra.v3i2.140","url":null,"abstract":"<p><p>One of the most difficult procedures in interventional cardiology is the percutaneous coronary intervention (PCI) on a chronic total occlusion (CTO) lesion case. To rate the difficulty of guidewire crossing, several angiographic scoring methods have been developed such as the Japan CTO (J-CTO) score. Here we demonstrate the advantages of revascularization using PCI procedure in a CTO case with intractable heart failure. A 53-year-old man presented to the emergency room of Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia with acute decompensated heart failure. The patient had a history of past PCI with two patent drug eluting stents (DES): one in the left main (LM)-left anterior descending (LAD) artery and one in the distal left circumflex (LCX) artery. The patient had three times rehospitalizations in the last three months. According to single-photon emission computed tomography (SPECT) imaging, the right coronary artery was remained functional; however, the lesion was categorized into very difficult level (J-CTO >3). The PCI was carried out on the right coronary artery and the blood vessel was successfully revascularized after applying multiple techniques. Following the procedure, the heart failure was treated and the 6-minute walking test (6MWT) that performed 12 days after the PCI increased from 220 to 260 meters. The success of this case depended on a comprehensive history taking, adequate imaging methods, and the selection of the proper tools and PCI strategy. In conclusion, despite the challenges, PCI is still an option for patients with persistent complete occlusion. The PCI requires comprehensive preparation and the use of angiographic scoring systems, such as the J-CTO score, to determine the approach and the likelihood of success.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 2","pages":"e140"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of Aceh Health Insurance (Jaminan Kesehatan Aceh) 2013-2021: Has health equity been achieved for all Acehnese after armed conflict? 2013-2021 年亚齐健康保险(Jaminan Kesehatan Aceh)的实施情况:武装冲突后所有亚齐人是否实现了健康公平?
Pub Date : 2023-04-01 Epub Date: 2023-04-30 DOI: 10.52225/narraj.v3i1.160
Muhammad Yani, Mahlil Ruby, Diah A Puspandari, Munawar Munawar, Kamal Fachrurrozi, Isfanda Isfanda, Aditya Candra, Teuku M Ilzana, Teuku M Khaled, Cut R Rahmi

Aceh Health Insurance (Jaminan Kesehatan Aceh-JKA) has been implemented since 2010 to increase the health equity by covering the health expenses and guaranteeing that all Acehnese are covered regardless of their economic, educational, and social statuses. However, since its implementation, there has been no study on its impact on health quality, particularly regarding the utilization of the main referral hospital (Dr Zainoel Abidin Hospital located in Banda Aceh) and the effects of the geographic accessibility and the number of specialist doctors in each regency/city on hospital utilization. This retrospective study assessed the equity factors during the Aceh Health Insurance implementation and during its integration to National Health Insurance (Jaminan Kesehatan Nasional-JKN) from 2013 to 2021 using data of travel time (time spent for travelling from the origin regency/city of referred patients to the main referral center) and healthcare resources (number of specialist doctors). The data were analyzed using Student's t-tests, Kolmogorov-Smirnov or Mann-Whitney U test when appropriate. Williamson Index was calculated to determine the disparities of health equity between regencies. Our data indicated the noticeably increase of health facilities utilization since the implantation of Aceh Health Insurance. However, there was no equity in the use of main referral facility by the residents in Aceh - was dominated by residents who lived closer and from more populated regencies/cities. In conclusion, there are accessibility and financial hardship barriers in accessing the health care facilities during the implementation of Aceh Health Insurance that need to be addressed by the government to achieve the health equity for all Acehnese.

亚齐健康保险(Jaminan Kesehatan Aceh-JKA)自 2010 年开始实施,旨在通过支付医疗费用来提高医疗公平性,并保证所有亚齐人,无论其经济、教育和社会地位如何,都能获得保险。然而,自该计划实施以来,尚未研究过该计划对医疗质量的影响,尤其是对主要转诊医院(位于班达亚齐的扎伊努埃勒-阿比丁医生医院)的利用率,以及各县/市的地理可达性和专科医生数量对医院利用率的影响。这项回顾性研究利用旅行时间(从转诊病人的原籍县/市到主要转诊中心所花费的时间)和医疗资源(专科医生数量)数据,评估了亚齐医疗保险实施期间以及从2013年到2021年与国家医疗保险(Jaminan Kesehatan Nasional-JKN)合并期间的公平因素。数据分析采用学生 t 检验、Kolmogorov-Smirnov 检验或 Mann-Whitney U 检验。通过计算威廉姆森指数来确定各地区之间的卫生公平差距。我们的数据表明,自亚齐医疗保险实施以来,医疗设施的利用率明显提高。然而,亚齐居民在使用主要转诊设施方面并不公平--主要是居住较近和来自人口较多地区/城市的居民。总之,在亚齐医疗保险实施期间,居民在使用医疗设施方面存在可及性和经济困难方面的障碍,需要政府加以解决,以实现所有亚齐人的医疗公平。
{"title":"Implementation of Aceh Health Insurance (<i>Jaminan Kesehatan Aceh</i>) 2013-2021: Has health equity been achieved for all Acehnese after armed conflict?","authors":"Muhammad Yani, Mahlil Ruby, Diah A Puspandari, Munawar Munawar, Kamal Fachrurrozi, Isfanda Isfanda, Aditya Candra, Teuku M Ilzana, Teuku M Khaled, Cut R Rahmi","doi":"10.52225/narraj.v3i1.160","DOIUrl":"10.52225/narraj.v3i1.160","url":null,"abstract":"<p><p>Aceh Health Insurance (<i>Jaminan Kesehatan Aceh</i>-JKA) has been implemented since 2010 to increase the health equity by covering the health expenses and guaranteeing that all Acehnese are covered regardless of their economic, educational, and social statuses. However, since its implementation, there has been no study on its impact on health quality, particularly regarding the utilization of the main referral hospital (Dr Zainoel Abidin Hospital located in Banda Aceh) and the effects of the geographic accessibility and the number of specialist doctors in each regency/city on hospital utilization. This retrospective study assessed the equity factors during the Aceh Health Insurance implementation and during its integration to National Health Insurance (<i>Jaminan Kesehatan Nasional</i>-JKN) from 2013 to 2021 using data of travel time (time spent for travelling from the origin regency/city of referred patients to the main referral center) and healthcare resources (number of specialist doctors). The data were analyzed using Student's t-tests, Kolmogorov-Smirnov or Mann-Whitney U test when appropriate. Williamson Index was calculated to determine the disparities of health equity between regencies. Our data indicated the noticeably increase of health facilities utilization since the implantation of Aceh Health Insurance. However, there was no equity in the use of main referral facility by the residents in Aceh - was dominated by residents who lived closer and from more populated regencies/cities. In conclusion, there are accessibility and financial hardship barriers in accessing the health care facilities during the implementation of Aceh Health Insurance that need to be addressed by the government to achieve the health equity for all Acehnese.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"3 1","pages":"e160"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Narra J
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1